TNF-α antagonist infliximab in the treatment of depression in older adults: results of a prematurely ended, randomized, placebo-controlled trial

MeSH terms

• Age Factors
• Aged
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use*
• Depressive Disorder / drug therapy*
• Depressive Disorder / immunology
• Depressive Disorder / psychology
• Early Termination of Clinical Trials* / trends
• Female
• Follow-Up Studies
• Humans
• Infliximab
• Male
• Pilot Projects
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*
• Tumor Necrosis Factor-alpha / immunology